Engineered Yeast Arabitol Fermentation With Reduced Byproducts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods of xylitol production are costly and environmentally inefficient, and there is a need for a sustainable alternative that minimizes overlap with metabolic pathways for other fermentation products like arabitol and erythritol.
Innovation Solution
Genetically engineered yeast cells, such as Moniliella pollinis, expressing an exogenous arabitol 2-dehydrogenase (ARD2DH) enzyme, are used to produce arabitol efficiently, reducing erythritol and glycerol production while maintaining high arabitol yields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional chemically catalyzed hydrogenation methods are used for xylitol production, then production capacity is achieved, but environmental cost and operational complexity increase due to high temperatures, pressures, and metal catalysts required
Solution Approach 1:
The patent replaces the mechanical/chemical hydrogenation system with a biological fermentation system. Instead of using metal catalysts, high temperatures, and high pressures, the invention uses genetically engineered yeast cells that metabolically convert xylose to xylitol under mild, ambient conditions through engineered metabolic pathways
Solution Approach 2:
The patent fundamentally changes the operating parameters from extreme conditions (high temperature, high pressure, chemical catalysts) to benign biological conditions (ambient temperature, atmospheric pressure, biological catalysts). The metabolic flux is redirected through engineered pathways to achieve high xylitol yield under sustainable conditions
2Productivity
If metabolic pathways are optimized for xylitol production, then xylitol yield improves, but overlap with pathways for other products (arabitol, erythritol, ribitol) creates competing reactions that reduce specificity
Solution Approach 1:
The patent segments the metabolic pathway into distinct, controlled sections using separate expression cassettes for each enzyme (xylA, xylB, xylC, xylD, xylE, xylF genes). This modular approach allows independent optimization and control of each enzymatic step, preventing unwanted cross-reactions with other metabolic pathways
Solution Approach 2:
The patent introduces intermediary enzymes and metabolic nodes that channel carbon flux specifically toward xylitol production. The engineered pathway includes intermediate metabolites and enzyme complexes that act as mediators to direct traffic away from competing pathways that produce arabitol, erythritol, or ribitol
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered yeast cells achieve high arabitol titers of 0.2 to 2.0 g/L with reduced byproduct production, offering a cost-effective and sustainable fermentation process.
Implementation Method 1
an arabitol 2-dehydrogeanse (ARD2DH) enzyme comprising a sequence at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99%, or 100% identical to at least one of SEQ ID NOs:1, 2, 3, 9, or 11
Implementation Method 2
fermentation processes have been used commercially at large scale to produce other organic molecules, such as ethanol, citric acid, lactic acid, and the like
Data Source
AI summary
Disclosed herein are genetically engineered yeast cells capable of producing arabitol. The engineered yeast cell may comprise an exogenous polynucleotide sequence encoding an arabitol 2-dehydrogeanse (ARD2DH) enzyme comprising a sequence at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99%, or 100% identical to at least one of SEQ ID NOs: 1, 2, 3, 9, or 11.